About
Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's
Novo Holdings, the primary shareholder of Novo Nordisk A/S and Novozymes A/S, manages a substantial investment portfolio with a focus on long-term returns. As the asset management arm of the Novo Nordisk Foundation—one of the world’s largest philanthropic enterprise foundations—Novo Holdings plays a central role in stewarding the Foundation's wealth. In addition to handling a broad mix of equities, bonds, real estate, infrastructure, and private equity assets, Novo Holdings is a global leader in life sciences investment. Through its Seeds, Venture, Growth, and Principal Investments teams, the company supports life science companies at every stage of development
Identity
| Name | Novo Holdings |
|---|---|
| Slug | novo-holdings |
| Type / kind | holding |
| Source _id | vMSYgEfoqIjv34hmltGXxcL2NnxPB19fcwUpY7ljG4ym9tvBDEvy5f |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country | Denmark |
|---|---|
| HQ country code | DK |
| HQ city | Hellerup |
| HQ address | Tuborg Havnevej 19, 2900 Hellerup, Denmark |
Web & social
| Website | https://novoholdings.dk/ |
|---|---|
| https://www.linkedin.com/company/2229 |
Funding
| Total raised | — |
|---|
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}